Using a new technology and computational method, researchers from Fred Hutch Cancer Center and The University of Texas MD Anderson Cancer Center have uncovered a biomarker capable of accurately ...

Q4 2024 Management View CEO Emil Kakkis highlighted 2024 as a pivotal year, with progress in six late-stage programs and a 29% revenue growth over 2023. He confirmed exceeding the upper end of revenue ...